Special Issue "Novel Organic Compounds towards the Discovery of Antioxidants"

A special issue of Molbank (ISSN 1422-8599). This special issue belongs to the section "Organic Synthesis".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 644

Special Issue Editors

Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Complutense University, Plaza De Ramon y Cajal, S/N University City, Madrid, Spain
Interests: organic chemistry; medicinal chemistry; organic synthesis; organic compound analysis; NMR
Department of Chemistry in Pharmaceutical Sciences, Faculty of Pharmacy, Complutense University, Plaza De Ramon y Cajal, S/N University City, Madrid, Spain
Interests: enzymatic synthesis of drugs and bioactive compounds; sustainable processes; biocatalyst upgrading; pharmaceutical industry; organic chemistry; pharmaceutical chemistry
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Oxidative stress is involved in many pathogenetic processes and it is often one of the main factors able to induce metabolic, cardiovascular and neurodegenerative diseases. For instance, it is one of the etiologic factors causing diabetes, arterial atherosclerosis and lateral amyotrophic sclerosis.

ROS and RNS play important physiologic and pathologic roles at the same time, so design and discovery of new drugs able to modulate ROS and RNS synthesis and oxidative stress in general would be very useful for the prevention and treatment of many diseases. Edaravone represents a clear example of an active heterocycle compound whose one action mechanism is based on its free radical scavenging activity.

Heterocycle systems as potential structures for free radical inhibition were basically unexplored until ten years ago. Just over one hundred papers have been published on this topic over the last ten years; for this reason, it constitutes a special field to be explored. The main goal of this Special Issue is to encourage authors to report all new aspects related to the development of new heterocycle systems that are active as free radical inhibitors.

Dr. Giorgio Giorgi
Prof. Dr. Andres R. Alcantara
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molbank is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • organic chemistry
  • medicinal chemistry
  • organic synthesis
  • free radicals
  • antioxidant activity
  • aromatic heterocycles
  • fused heterocycles
  • nitrogen
  • oxygen
  • sulfur
  • spectroscopic properties
  • radicals

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop